Summary
- Current Price
- As of today, GYRE price is $7.56, down -3.20% on
- Current Price All-Time High
- GYRE price is currently -99.98% below its historical high of $47,990.25 set on
- Market Cap
- GYRE current market cap is $728M, down -29.51% year-over-year
- PE Ratio
- GYRE current PE ratio is 353.04
- Revenue
- GYRE current annual revenue is $116.59M, up +10.24% year-over-year
- Next Earnings
- The next earnings release for GYRE is on
Profile
| Metric | Value |
|---|---|
| Full Name | Gyre Therapeutics, Inc. |
| Ticker | NASDAQ: GYRE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | gyretx.com |
| Employees | 579 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $7.56 | |
| Price, 1D Change | -3.20% | |
| $728M | ||
| - | ||
| 353.04 | ||
| 1.42 | ||
| $117M | ||
| Revenue, 1Y Change | +10.24% | |
| $0.02 | ||
| EPS, 1Y Change | -58.42% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $7.20 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:15 | |
| Next Split | N/A | N/A |
| Last Ticker Change | CBIO | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.02 | ||
| EPS Estimate | N/A | -$0.02 |
| EPS Est. Change | N/A | -200.00% |
| $116.59M | ||
| Revenue Estimate | N/A | $148.00M |
| Revenue Est. Change | N/A | +26.94% |
| Current Price | $7.56 | |
| Price Target | - | $18.00 |
| Price Tgt. Change | - | +138.25% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$1.41 | - | |
| - | $0.05 | - | |
| $0.13 | $0.02 | -84.62% | |
| -$0.02 | N/A | -200.00% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $113.45M | $113.45M | 0.00% | |
| $101.39M | $105.76M | +4.31% | |
| $114.83M | $116.59M | +1.53% | |
| $148.00M | N/A | +26.94% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $7.56 | |
| $7.79 | ||
| SMA 200 vs Price | +3.07% | |
| $7.93 | ||
| SMA 50 vs Price | +4.92% | |
| 1.42 | ||
| $0.55 | ||
| 43.13 | ||
| 88.07% | ||
| 85.99% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $7.20 | |
| Upcoming | N/A | N/A |
| - | ||
| Total Dividend | - | |
| - | ||
| - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $116.59M | ||
| $0.02 | ||
| $111.17M | ||
| 95.35% | ||
| $11.49M | ||
| 9.86% | ||
| $9.88M | ||
| 8.47% | ||
| - |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 5.60 | ||
| 5.04 | ||
| - | ||
| - | ||
| 19.27 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 353.04 | ||
| 6.24 | ||
| 6.86 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $106.03M | ||
| $52.43M | ||
| $166.13M | ||
| $102.37M | ||
| $23.85M | ||
| $18.29M | ||
| $939.00K | ||
| $636.00K | ||
| $124.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $111.56M | ||
| $99.68M | ||
| $5.42M | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $4.56M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Jefferies | ||
| HC Wainwright & Co. |
Analyst sentiment
Institutional ownership
Screeners with GYRE
FAQ
What is the ticker symbol for Gyre Therapeutics, Inc.?
The ticker symbol for Gyre Therapeutics, Inc. is NASDAQ:GYRE
Does Gyre Therapeutics, Inc. pay dividends?
No, Gyre Therapeutics, Inc. does not pay dividends
What sector is Gyre Therapeutics, Inc. in?
Gyre Therapeutics, Inc. is in the Healthcare sector
What industry is Gyre Therapeutics, Inc. in?
Gyre Therapeutics, Inc. is in the Biotechnology industry
What country is Gyre Therapeutics, Inc. based in?
Gyre Therapeutics, Inc. is headquartered in United States
When did Gyre Therapeutics, Inc. go public?
Gyre Therapeutics, Inc. initial public offering (IPO) was on April 12, 2006
Is Gyre Therapeutics, Inc. in the S&P 500?
No, Gyre Therapeutics, Inc. is not included in the S&P 500 index
Is Gyre Therapeutics, Inc. in the NASDAQ 100?
No, Gyre Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Gyre Therapeutics, Inc. in the Dow Jones?
No, Gyre Therapeutics, Inc. is not included in the Dow Jones index
When was Gyre Therapeutics, Inc. last earnings report?
Gyre Therapeutics, Inc.'s most recent earnings report was on November 7, 2025
When does Gyre Therapeutics, Inc. report earnings?
The next expected earnings date for Gyre Therapeutics, Inc. is May 7, 2026
Data Sources & References
- GYRE Official Website www.gyretx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1124105/000119312526106251/0001193125-26-106251-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1124105/000119312526106251/0001193125-26-106251-index.htm
- GYRE Profile on Yahoo Finance finance.yahoo.com/quote/GYRE
- GYRE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gyre